Asthma: Spiriva® (tiotropium) Respimat® becomes the only LAMA licensed in asthma care
1 October 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced that adult asthma patients could benefit from a new treatment...
List view / Grid view
News
Cardio3 BioSciences announces new business development strategy to broaden its product pipeline
1 October 2014 | By Cardio3 BioSciences
Cardio3 BioSciences announces that it has recently increased its business development activities, building on its core expertise in cellular therapies and in cardiovascular diseases...
DKSH extends partnership with Novo Nordisk in Malaysia
1 October 2014 | By DKSH Business Unit Healthcare
DKSH, the leading Market Expansion Services provider with a focus on Asia, signed an agreement to provide commercial and distribution services to Novo Nordisk, a global healthcare company with 90 years of experience in diabetes care, in Malaysia...
Celerion expands ophthalmological capabilities to patient populations in collaboration with Queen’s University, Belfast
30 September 2014 | By Celerion
Celerion, announces the expansion of ophthalmological services in our Belfast, Northern Ireland UK facility, by building on our successful relationship with Queen’s University in Belfast...
Quotient Clinical showcases RapidFACT™ and six poster publications at AAPS
30 September 2014 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics™ company, will present the third annual RapidFACT™ (Rapid Formulation development And Clinical Testing) User Group Meeting...
US allergic rhinitis treatment market value to see fourfold increase by 2018, says GlobalData
30 September 2014 | By GlobalData
The US market value for allergic rhinitis treatment will rise rapidly from $172.5 million in 2013 to $688.25 million by 2018, at an impressive Compound Annual Growth Rate (CAGR) of 31.88%, according to research and consulting firm GlobalData...
Roche purchases shares in tender offer for InterMune, Inc.
30 September 2014 | By Roche
Roche and InterMune, Inc. announced that Roche’s wholly owned subsidiary Klee Acquisition Corporation has accepted for payment all shares validly tendered pursuant to its tender offer for all outstanding shares of common stock of InterMune, Inc. at USD 74.00 per share in cash...
Roche’s Perjeta regimen extended the lives of people with an aggressive type of metastatic breast cancer by 15.7 months compared to Herceptin and chemotherapy
30 September 2014 | By Roche
Roche announced final survival results from the Phase III CLEOPATRA study, which showed that adding Perjeta (pertuzumab) to Herceptin (trastuzumab) and docetaxel chemotherapy extended the lives of people with previously untreated HER2-positive metastatic breast cancer...
Cresset donates to Novartis’s TExts to Sub-Saharan Africa (TESSA) project
30 September 2014 | By kdm communications
Cresset, innovative provider of computational chemistry software and services, has provided a donation to Novartis Institutes for Biomedical Research’s (NIBR) in support of their TExts to Sub-Saharan Africa (TESSA) project...
Global medical manufacturers turn to distributors to tap the Eastern European market
30 September 2014 | By Frost & Sullivan
Distributors are expected to deploy a multi-sector, multi-brand strategy to broaden their business, says Frost & Sullivan...
AstraZeneca updates on progress of oncology pipeline at ESMO 2014 congress
29 September 2014 | By AstraZeneca
AstraZeneca will present new data from its pipeline of investigational cancer medicines over the next three days at the European Society of Medical Oncology (ESMO) 2014 Congress in Madrid...
Roche presents preliminary combination data for anti-PDL1 medicine (MPDL3280A) with Avastin (bevacizumab)
29 September 2014 | By Roche
Roche has announced the first combination data of its investigational cancer immunotherapy MPDL3280A and Avastin in untreated patients with mRCC...
Digitron extends its range of high quality hand-held digital thermometers
29 September 2014 | By kdm communications
Digitron – an Elektron Technology brand – has announced new additions to its extensive range of robust hand-held digital thermometers...
CHMP announces positive opinion for rezolsta™, a new once-daily, fixed-dose HIV therapy combining darunavir and cobicistat
29 September 2014 | By Janssen
Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a Positive Opinion recommending REZOLSTA™...
SIGMOID enters into a licence agreement with Pendopharm for commercialisation rights to CyCol® in Canada
29 September 2014 | By Sigmoid Pharma Limited
SIGMOID PHARMA LIMITED and Pendopharm have entered into agreements concerning a licence for exclusive rights to commercialise CyCol® in the Canadian market and an equity investment in SIGMOID...
